Wei-Li Shao - 05 Jun 2025 Form 3 Insider Report for Omada Health, Inc. (OMDA)

Role
President
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Wei-Li Shao
Issuer symbol
OMDA
Transactions as of
05 Jun 2025
Net transactions value
$0
Form type
3
Filing time
05 Jun 2025, 16:38:29 UTC
Next filing
09 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shao Wei-Li President C/O OMADA HEALTH, INC., 500 SANSOME STREET, SUITE 200, SAN FRANCISCO /s/ Nathan Salha, as Attorney-in-Fact for Wei-Li Shao 05 Jun 2025 0002069137

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 258,333 $5.82 Direct F1, F2
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 33,333 $6.30 Direct F1, F2
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 21,869 $6.81 Direct F1, F2
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 40,000 $6.81 Direct F1, F2
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 100,000 $9.18 Direct F2, F3
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 7,333 $9.18 Direct F1, F2
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 166,666 $4.74 Direct F2, F4
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 83,333 $8.01 Direct F2, F5
holding OMDA Stock Option (Right to Buy) 05 Jun 2025 Common Stock 108,333 $7.68 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested and exercisable.
F2 Reflects a 1-for-3 reverse stock split of the Issuer's outstanding common stock effected on May 27, 2025.
F3 1/48th of the shares subject to the option vest on each monthly anniversary measured from September 1, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F4 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F5 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F6 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Exhibit 24.1 - Power of Attorney